Literature DB >> 23311845

Assessing ESCROs: yesterday and tomorrow.

Henry T Greely1.   

Abstract

Mesh：

Year:  2013        PMID： 23311845     DOI： 10.1080/15265161.2013.747340

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN： 1526-5161            Impact factor:   11.229


× No keyword cloud information.
  6 in total

1.  Research ethics and stem cells: Is it time to re-think current approaches to oversight?

Authors:  Timothy Caulfield; Kalina Kamenova; Ubaka Ogbogu; Amy Zarzeczny; Jay Baltz; Shelly Benjaminy; Paul A Cassar; Marianne Clark; Rosario Isasi; Bartha Knoppers; Lori Knowles; Gregory Korbutt; James V Lavery; Geoffrey P Lomax; Zubin Master; Michael McDonald; Nina Preto; Maeghan Toews
Journal:  EMBO Rep       Date:  2014-12-04       Impact factor: 8.807

2.  Time to ditch stand-alone stem cell oversight panels, experts say.

Authors:  Elie Dolgin
Journal:  Nat Med       Date:  2013-03       Impact factor: 53.440

3.  ESCRO committees--not dead yet.

Authors:  Mary Devereaux; Michael Kalichman
Journal:  Am J Bioeth       Date:  2013       Impact factor: 11.229

4.  Promoting public trust: ESCROs won't fix the problem of stem cell tourism.

Authors:  Zubin Master; David B Resnik
Journal:  Am J Bioeth       Date:  2013       Impact factor: 11.229

Review 5.  Ethical issues in stem cell research and therapy.

Authors:  Nancy Mp King; Jacob Perrin
Journal:  Stem Cell Res Ther       Date:  2014-07-07       Impact factor: 6.832

Review 6.  An overview on ethical considerations in stem cell research in Iran and ethical recommendations: A review.

Authors:  Tahmineh Farajkhoda
Journal:  Int J Reprod Biomed (Yazd)       Date:  2017-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.